Sign for Notice Everyday    Sign Up| Sign In| Link| English|

Our Sponsors

    Receive Latest News

    Feedburner
    Share Us


    FMEA & Risk Management for Medical Devices

    View: 140

    Website https://www.traininng.com/webinar/-200664live?channel=ourglocal-march_2019_SEO | Want to Edit it Edit Freely

    Category online training courses for hr professionals,online training programs for hr professionals, HR Training and Development

    Deadline: March 26, 2019 | Date: March 26, 2019

    Venue/Country: Online Event, U.S.A

    Updated: 2019-02-28 16:08:35 (GMT+9)

    Call For Papers - CFP

    Overview

    FMEA (Failure Mode Effects Analysis) has long been recognized as a valuable tool in risk assessment and should be considered as an integral part of risk management.

    FMEA has been used as part of Risk Analysis under the obsolete standard EN 1441 -Risk Analysis for Medical Devices. The term "Risk Analysis" is no longer appropriate for medical device manufacturers and has been replaced by "Risk Management".

    EN 1441 is now a withdrawn standard and ISO 14971:2007 Medical Devices Application of Risk Management to Medical Devices has been the harmonized standard for risk assessment of medical devices under the medical devices directives and has been emphasized in the new ISO 13485:2016.

    This presentation will acquaint one with the various terms used in risk management and the importance of ISO 14971 & ISO 13485 in the managements of risks during the life cycle of medical devices starting with design and manufacture.

    Why should you Attend

    The importance of Risk Management is currently emphasized by FDA and ISO 13485:2016 for all QMS processes with FMEA a key tool for good reasons, including recalls and other significant economic losses.

    Failure to understand the relationship between risk and economics will put you at a loss while the rest of the team embraces the program.

    Areas Covered in the Session

    FMEA & FMECA

    Risk Management vs. ISO 13485

    Risk Management & ISO 14971

    FDA's Risk Management Requirements

    Design Control Risk Management

    Medical Device Directives & Risk Management

    Who Will Benefit

    Quality & Regulatory Professionals

    Quality System Auditors

    Manufacturing & Design Engineers

    Marketing Product Managers

    Operations Executives

    Speaker Profile

    John Chapman, BS, MBA, RAC has over 35 years medical device regulatory & compliance experience and over 15 years experience with the European Union's medical device directive, 93/42/EEC. John has led two device companies to ISO quality system certification and CE marking.

    He has been performed regulatory due diligence on over a dozen acquisitions in the past 12 years, exposing him to numerous quality systems, including consent decrees as well as many notified bodies. John has participated in several FDA remediation projects involving non-compliance with all QMS sub-systems. He earned his regulatory affairs certification (RAC) in 1998 and was a contributing author to 2004 Fundamentals of EU Regulatory Affairs, RAPS, 2004. He co-founded a local RAPS chapter and has been a speaker at these meetings and the annual RAPS conference.

    Event link: https://www.traininng.com/webinar/-200664live?channel=ourglocal-march_2019_SEO

    Contact Info

    Traininng.com LLC

    Email: traininngdotcomatgmail.com

    Phone: US: (510) 962-8903

    Phone: Zurich: +41 - 43 434 80 33

    Website : https://www.traininng.com


    Keywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
    Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.